CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma

We developed a computational pipeline designed to use RNA sequencing (n = 136) and gene expression profiling (n = 250) data from neuroblastoma tumors to identify cell surface proteins predicted to be highly expressed in MYCN amplified neuroblastomas and with little or no expression in normal human t...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Oncol
Auteurs principaux: Sussman, Robyn T., Rokita, Jo Lynne, Huang, Kevin, Raman, Pichai, Rathi, Komal S., Martinez, Daniel, Bosse, Kristopher R., Lane, Maria, Hart, Lori S., Bhatti, Tricia, Pawel, Bruce, Maris, John M.
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2020
Sujets:
Oncology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7069022/
https://ncbi.nlm.nih.gov/pubmed/32211329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00302
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires